Abstract Submission
⚡ ALL INFORMATION CLICK HERE 👈🏻👈🏻👈🏻
Abstract Submission
Wednesday, 23 March 2022
Abstract Submission
Tuesday, 4 October 2022
(23:59 EDT)
Abstract Submission Deadline
25 November 2022
Abstract Notifications
Rue François-Versonnex 7,
1207 Geneva, Switzerland.
IPVC 2023. All Rights Reserved. Terms of Use | Privacy Policy | Cookie Policy
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the ...
These Cookies are necessary for the Services to function properly and cannot be disabled. They are usually only set, in response to actions made by you, enabling functions like navigation, or setting preferences. These Cookies do not store information about you that will be used for other purposes.
These Cookies enable the Services to provide enhanced functionality and personalization. They may be set by us (first-party Cookies) or by third-party providers who work with us (third-party Cookies).
These Cookies are for internal use only. They help us to secure and maintain our Services, and to remember your preferences for tools found on the Services. They are also used for gathering analytics data on how you interact with our Services and the improvement performance of the site accordingly. If you do not allow these Cookies, we will not know when you have visited our site.
These Cookies make advertisement more relevant to you. Our advertising partners may use it to show you relevant ads on different websites by uniquely identifying your browser and internet device.
All abstracts must be submitted via this webpage. Please note that the Conference Secretariat is not able to accept abstracts submitted via e-mail, fax or post.
Please choose one of the following presentation types:
*Short orals will not be available for Basic Science
The Scientific Committee will determine whether the abstract will be accepted for presentation, with consideration given to the author’s preference.
The submitting author should also be the author for correspondence. An individual may be the submitting author on any number of abstracts.
The presenting author may or may not be the submitting/corresponding author. An individual may be the presenting author on a maximum of 3 abstracts.
The submitting/corresponding author accepts that the content of the abstract cannot be modified or corrected after final submission and that it will be published exactly as submitted.
During abstract submission you will be asked to confirm that you agree to the following:
If you have any questions, please contact us at abstracts@kenes.com .
IPVS is a not-for-profit organization and the global authority on papillomaviruses. Our mission is to contribute to the elimination of human and animal papillomaviruses and their associated diseases.
Give us a call or fill in the form below and we will contact you. We endeavor to answer all inquiries within 24 hours on business days.
To help offer the best experience possible, RSNA uses cookies on its site. By browsing here, you acknowledge our terms of use. To find more information about our cookie policy visit
here .
To help offer the best experience possible, RSNA uses cookies on its site. By browsing here, you acknowledge our terms of use. To find more information about our cookie policy visit
here .
Continue to enjoy the benefits of your RSNA membership.
The latest from RSNA journals on COVID-19
Continuing medical education (CME)
AI resources and training
Imaging AI in Practice
RSNA Imaging AI Certificate
AI challenges
Professionalism and quality care
Education awards
Regional Spotlight Courses
Explore programs in grant writing, research development and academic radiology.
Learn about tools to help radiologists work more efficiently.
Explore our library of cases to aid in diagnosis, submit your own or become a reviewer.
3D Printing & Mixed Reality Showcase
RSNA Cervical Spine Fracture AI Challenge (2022)
COVID-19 AI Detection Challenge (2021)
RSNA Pulmonary Embolism Detection Challenge (2020)
RSNA Intracranial Hemorrhage Detection Challenge (2019)
RSNA Pneumonia Detection Challenge (2018)
RSNA Pediatric Bone Age Challenge (2017)
Employing Humor in the Radiology Workplace
Quality Improvement Certificate Program
National Imaging Informatics Curriculum and Course
RSNA Journals: Trainee Editorial Boards
Molecular Imaging Education Resources
Derek Harwood-Nash International Fellowship
Clinical Trials Methodology Workshop
Comparative Effectiveness Research Training (CERT)
Creating and Optimizing the Research Enterprise (CORE)
Introduction to Academic Radiology for Junior Faculty (ITARJF)
Introduction to Academic Radiology for Scientists (ITARSc)
Introduction to Research for International Young Academics
Value of Imaging through Comparative Effectiveness Program (VOICE)
Writing a Competitive Grant Proposal
Derek Harwood-Nash International Education Scholar Grant
Education Research Development Grant
Kuo York Chynn Neuroradiology Research Award
Roentgen Centennial Commemorative Medal
Roentgen Resident/Fellow Research Award
Quantitative Imaging Biomarkers Alliance
QIBA Conformance Certificate Services
Quantitative Imaging Data Warehouse (QIDW)
The Quantitative Imaging Data Warehouse (QIDW) Contributor Request
Integrating the Healthcare Enterprise
Board of Directors: Call for nominations
Annual Oration in Diagnostic Radiology
Annual Oration in Radiation Oncology
A variety of presentation types provide meeting attendees with wide-ranging opportunities to learn. Abstracts are considered in several formats.
Hypothesis-driven research that may be submitted as a paper to be presented orally or as a digital poster.
Education exhibits should be designed to teach or review topics related to medical imaging. They may be presented as hardcopy or digital posters.
A presentation of quality assessment and improvement initiatives aimed at improving patient care in radiology. Reports may be presented as hardcopy or digital posters and all require an oral presentation.
All abstracts are evaluated through a double-blind peer-review process.
RSNA recognizes top presentations with the following awards.
A $3,000 prize awarded to the top scientific paper in neuroradiology as selected by the Annual Meeting Program Planning Committee.
A $1,000 prize is awarded to an outstanding scientific presentation in each subspecialty presented by a resident, fellow, medical student or physics trainee.
All eligible education exhibits are reviewed by the Education Exhibits Awards Committee appointed by the board of directors and awards are announced at the annual meeting.
All eligible quality improvement report exhibits are reviewed and awards are announced at the start of the Wednesday afternoon plenary.
The requirement for financial disclosure from committee members, planners, reviewers, authors, and presenters is a mandatory element in maintaining ACCME accreditation for all organizations that provide continuing education (CE) activities. If an individual refuses to disclose, he/she will not be permitted to participate as a planner, committee member, reviewer, author, or presenter.
Thank you for contributing to our Cutting-Edge Research call for abstracts! Abstract submissions are now closed.
If you have questions, please contact us at programs@rsna.org or call 1-877-776-2227 (within U.S.) or 1-630-590-7774 (outside U.S.).
For technical support, please contact us at rsna@support.ctimeetingtech.com or call 1-217-398-1792.
Submit abstracts for consideration using an online submission program, which allows you to save and edit your work during the submission period. All abstracts must be submitted online by the posted deadlines in order to be considered for acceptance.
You retain the copyright of your content and agree to give RSNA a limited, nonexclusive, royalty-free license to present and archive the content.
As an ACCME-accredited provider, the RSNA must ensure that education is fair and balanced and that any clinical content presented supports safe, effective patient care. The ACCME defines ineligible companies as "those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients."
Further, the provider must be able to show that individuals in a position to control the content of an education activity, including committee members, reviewers, planners, authors, and presenters, has disclosed all financial relationships with ineligible companies to the provider. Individuals in a position to control the content must disclose regardless of their view of the relevance of the relationship to the education. The provider must identify, mitigate, and disclose all identified financial relationships to an education activity being delivered to the learners.
If you have or have had within the previous 24 months such a relationship or affiliation, you must disclose this information. Likewise, disclosure that no relationship(s) exists is also required. The intent of this policy is not to prevent an individual with a financial relationship from participating; however, in accordance with ACCME standards, the RSNA has developed policies and procedures to manage identified financial relationships.
820 Jorie Blvd., Suite 200
Oak Brook, IL 60523-2251 USA
Copyright © 2022 Radiological Society of North America | Terms of Use | Privacy Policy | Cookie Policy | Feedback
Before submitting your abstract, ensure you read the below guidelines carefully – all information that you require is included below.
Advances in pain management Basic science related to rheumatic diseases Behcet’s disease and miscellaneous rheumatic conditions Clinical immunology related to rheumatic diseases COVID-19 Epidemiology, COPCORD, health care system and pharmacoeconomics Fibromyalgia Genetics Imaging techniques and diagnosis Infection-related rheumatic diseases Innovation in research tools i.e. big data, precision medicine Innovative medical technology i.e. Artificial Intelligence / machine learning Metabolic bone diseases and crystal-induced diseases Osteoarthritis Osteoporosis Paediatric rheumatology Psoriatic arthritis Rehabilitation for rheumatic diseases Rheumatoid arthritis anti-TNF therapy Rheumatoid arthritis bDMARDs Rheumatoid arthritis clinical aspects and co-morbidity Rheumatoid arthritis csDMARDs Rheumatoid arthritis non biological treatment Rheumatoid arthritis non-TNF biological therapies Rheumatoid arthritis prognosis, predictors and outcome Rheumatoid arthritis tsDMARDs Scleroderma, myositis and related syndromes Soft tissue rheumatism Spondylarthropathies biological and non-biological therapies Spondylarthropathies clinical aspects and co-morbidity Systemic lupus erythematosus, Sjogrens and antiphospholipid syndrome clinical aspects, comorbidities and complications Systemic lupus erythematosus, Sjogrens and antiphospholipid syndrome therapies Systemic vasculitis related to rheumatic diseases Telemedicine
Alternative medicine (e.g. acupuncture) Case Report COVID-19 Nursing Physiotherapy Psychological intervention and miscellaneous forms of care
All submitted abstracts will be peer reviewed (blind review) by a subsection of the APLAR 2022 Scientific Committee Incomplete abstracts or abstracts not written in English cannot be processed and will not be reviewed No revisions are possible after the submission deadline – no exceptions
CCPA - personal information opt out .
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the ...
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Выбрать язык китайский (традиционный) китайский (упрощенный) корейский японский
National Institutes of Health, United States
University Malaya Medical Centre, Malaysia
National University Hospital, Singapore
Peking Union Medical College Hospital, China
Department of Rheumatology and Infectious Diseases, Kitasato University, Japan
Shantou Central Hospital, New Zealand
Qazaq College Of Rheumatology, Kazakhstan
University Of The Philippines Manila, Philippines
Saitama Medical University/Keio University, Japan
University of Otago, Dunedin School of Medicine, New Zealand
Faculty Of Medicine, Chiang Mai University, Thailand
Post Graduate Institute of Medical Education And Research Chandigarh, India
Bangabandhu Sheikh Mujib Medical University, Bangladesh
Faculty Of Medicine Ramathibodi Hospital, Mahidol University, Thailand
Western Health, Melbourne University, Australia
Konkuk University School Of Medicine, South Korea
Pamela Youde Nethersole Eastern Hospital, Hong Kong
Queen Elizabeth Hospital, Hong Kong
Prince Of Wales Hospital, Chinese University Of Hong Kong, Hong Kong
Green Life Center For Rheumatic Care And Research, Bangladesh
Pakistan Society For Rheumatology (psr), Pakistan
College Of Specialists In Rheumatology & Rehabilitation Sri Lanka, Sri Lanka
University Malaya Medical Centre, Malaysia
Charité University Medicine , Berlin
The Chinese University of Hong Kong, Hong Kong
Universitätsklinikum Erlangen, Department of Medicine 3, Germany
University Of Alabama At Birmingham, United States
Peking University First Hospital, China
University of Michigan, United States
Philippine Rheumatology Association, Philippines
China-japan Friendship Hospital, China
Seoul Metropolitan Government-seoul National University Boramae Medical Center, South Korea
University Of Cape Town, South Africa
Prince Of Wales Hospital, Australia
Bar Ilan Universtiy/Albert Einstein College Of Medicine, United States
Centre For Health, Exercise & Sports Medicine, He Unversity Of Melbourne, Australia
Department of Rheumatology and infectious Diseases, Kitasato University, Japan
University of Pennsylvania, United States
The University Of Melbourne, Australia
University Of Santo Tomas, Philippines
Christian Medical College, Vellore, India
Division Of Rheumatology, Medical University Of Vienna, Austria
Singapore General Hospital, Singapore
Hong Kong Sanatorium & Hospital, Hong Kong
The University of Hong Kong, Hong Kong
Division Of Allergy, Immunology And Rheumatology, Department Of Internal Medicine, Taichung Veterans General Hospital, Taiwan
Kyorin university school of medicine, Japan
University of Michigan, United States
Connective Tissue Diseases Research Center, Tabriz University Of Medical Sciences, Tabriz, Iran
Education:
2008 Ph.D. (Dr. of Medical Science), Chiba University
2000 M.D. Chiba University School of Medicine
Professional Training and Employment:
2015-presentAssociate Professor in Department of Allergy and Clinical Immunology, Chiba University Hospital
2013-2015 Department of Allergy and Clinical Immunology, Chiba University Hospital
2012-2013 Research Fellow in Lupus and Vasculitis Clinic, Cambridge University Hospital, Cambridge, UK
2008-2011 Department of Allergy and Clinical Immunology, Asahi General Hospital
2004-2008Department of Allergy and Clinical Immunology, Chiba University Hospital
2003-2004 Internal Medicine, Yokohama Rousai Hospital
2001-2003Internal Medicine, Numazu City Hospital
2000-2001Resident in Internal Medicine, Chiba University Hospital
Certification:
2010 Japan College of Rheumatology-board Certified Rheumatologist
National Hospital & Medical Center; Central Park Medical College; FJMU; Arthritis Care Foundation, Pakistan
Vib Center For Inflammation Research; Ghent University, Belgium
The University Of Melbourne, Australia
Pamela Youde Nethersole Eastern Hospital, Hong Kong
Kk Women’s And Children’s Hospital, Duke-nus Medical School, Singapore
National University Hospital, Singapore
Kalinga Institute Of Medical Sicences, India
The Asia Pacific League of Associations for Rheumatology (APLAR) in conjunction with the Hong Kong Society of Rheumatology (HKSR) invite you to submit an abstract for possible inclusion in the official congress program. .
Accepted abstracts will be included in the official 2022 Congress program and published in an online supplement of International Journal of Rheumatic Diseases (IJRD).
Please diarise the following important program dates.
Submission opens: late February 2022
Author notifications: September 2022
Please contact program@aplarcongress.com if you have any questions regarding your submission or the program in general.
Abstracts can be submitted for either oral or poster presentations.
Oral presentations Oral presentations will be asked to present an oral presentation at the congress including a PowerPoint presentation and Q&A with the audience.
Poster presentations Poster presentations will be asked to present a visual poster display and potentially participate in a guided poster tour at the congress.
IMPORTANT Please enter submission information carefully, information will be published exactly as submitted
All abstract submissions must be received online through the abstract submission portal .
Abstract submissions are welcome under any of the below topics.
To expand either the clinical rheumatology or allied
18yo Fisting Com
Mother Jerk Son Incest Movie
Sissy Prozac On A Natural High